-
Tardive Dystonia Following Risperidone Treatment : A Case Report and Therapeutic Approach
-
Targeting miR-27 with Antisense Oligonucleotides for Disease Modification in Parkinson’s Disease
-
Task-Based Functional Imaging in Task-Specific Focal Dystonia during Dystonia-Related and -Unrelated Tasks
-
Tau Deposition in Locus Coeruleus is Associated with Rapid Eye Movement Sleep Behavior Disorder in Progressive Supranuclear Palsy.
-
TeleHD: Feasibility, Validity and Value of Telemedicine in Huntington Disease
-
Telemonitoring-assisted DBS Optimization For Parkinson’s Disease Patients
-
Temporal coordination of head and trunk during 360-degree turning in Parkinson’s Disease
-
Temporal prediction in cervical dystonia
-
Tension Pneumocephalus as an acute complication of STN-DBS surgery
-
Territorial inventory of training needs in nursing home for the support of patients with Parkinson’s syndrome
-
Tetradystonics patients may be misdiagnosed?
-
The “Cat Killer’s Disease”: Lived Experience of Parkinson’s disease Patients in Ethiopia
-
The 2-Minute Walking Test Predicts Aerobic Fitness, Motor Function, and Brain Health in Parkinson’s Disease
-
The 201 Trial in Untreated Parkinson’s Disease
-
The AIMS Clinic Model: A Retrospective Analysis of Interdisciplinary Neuropalliative Care for People with Advanced Parkinsonism
-
The alteration of GABA and glutamate in Parkinson’s disease is related to motor executive dysfunction: a 7T-MRS study
-
The assessment of anxiety and depression comorbidities and the DRN electrophysiology in a primate model of Parkinson’s Disease
-
The Association between Non-Motor Symptom Burden and Quality of Life in the Nigeria Parkinson Disease Research Network Registry
-
The Association of Pain with motor symptom severity in Parkinson’s Disease: A secondary data analysis
-
The association of Severity and Monogenetic Subgroups in Parkinson’s Disease
-
The Black and African American Connections to Parkinson’s Disease Study
-
The bypassing and embedded PEG J
-
The Cats-and-Dogs Test Predicts Cognitive Impairment in Parkinson’s Disease in a Diverse Population
-
The challenge to prevent Parkinson’s Disease with a new in vitro approach
-
The Challenges of Adaptive Deep Brain Stimulation: A Delphi Panel Study
-
The Challenges of Very Late-Onset Parkinson’s Disease: Perspectives from Patients, Primary Caregivers and Attending Physicians.
-
The characteristic and prognostic role of blood inflammatory markers in patients with Huntington’s disease from China
-
The Characteristics and Management of Patients with Dystonia Referred for The Troubleshooting of Deep Brain Stimulation Therapy: A Single Center Experience
-
The Clinical and Genetic Characteristics of HSP Patients by WES Sequencing Combined with MLPA
-
The clinical features, neuroimagings and outcomes of diabetic striatopathy: a retrospective study at tertiary hospital in Vietnam
-
The Clinical Implication of Dysphagia in Patients with Multiple System Atrophy
-
The Clinical Landscape of Progressive Supranuclear Palsy in an Underserved Community from Southwestern Colombia
-
The comorbidity conundrum in functional movement disorder: How are FMD patients with additional other FND different?
-
The Contribution of APOE4 Genotype on Structural MRI in Parkinson’s Disease: A Study from the PPMI Cohort
-
The Contribution of Cognitive and Affective Factors to Balance Control in People with Parkinson’s Disease Attending an Outpatient Clinic
-
The course of cognitive impairment in Parkinson’s disease patients with Сovid-19
-
The Current State of Wearable Device Use in Parkinson’s Disease (A Survey of Individuals with Parkinson’s and Specialist Clinicians)
-
the Degeneration of Locus Coeruleus and its Enhanced Causal Relationship to Neural Circuit in Parkinson’s Tremor
-
The dementia with Lewy bodies related metabolic brain pattern (DLBRP) – a multicentric validation
-
The development of an electronic motor symptoms diary for Parkinson’s disease using qualitative patient insights
-
The Differences in the Perception of Parkinson’s Disease-related Motor Complications between Patients and Physicians
-
The East London Parkinson Disease Project: updated results from engaging a diverse population in research
-
The Effect of an Exogenous Ketone Supplement on Gut Microbiota in Parkinson’s disease, a Pilot Study
-
The effect of comorbid chronic post-traumatic stress disorder in dream enactment behavior among veterans with Parkinson’s disease and REM sleep behavior disorder
-
The effect of Diabetes Mellitus and Cardiovascular disease on Parkinson’s disease
-
The Effect of Genotype on Voice & Swallowing in Parkinson’s Disease: A Parkinson’s Progression Markers Initiative Study
-
The Effect of Modulating Alpha-synuclein Aggregation on Clinical Outcome in the Presence of Standard-of-care Dopaminergic Therapy in Parkinson’s Disease. A Quantitative Systems Pharmacology Approach.
-
The Effect of Stochastic Resonance Stimulation in Neural Control of Balance During Walking in Parkinson Disease
-
The Effect of Subjective Postural Vertical on Forward Flexed Posture in Parkinson’s disease
-
The Effects of Baduanjin on Fine Motor Skills in Mild and Moderate Parkinson’s Disease
-
The effects of DL-3-n-butylphthalide in patients with mild cognitive impairment due to Parkinson’s disease: A multicenter, randomized, double-blind, placebo-controlled trial
-
The Fazekas scale score and the occurrence of adverse events after MRgFUS thalamotomy, is there a relationship?
-
The Feasibility and Practical utility of Virtual Visits for Patients with Parkinson’s disease in Different World Regions
-
The Feasibility of ICA in Parkinson’s Disease fMRI
-
The first Indian patient with Hereditary Spastic Paraparesis type 42 due to a de novo SLC33A1 variant
-
The First of Its Kind Genetics Cohort: the Black and African American Connections to Parkinson’s Disease (BLAAC PD) Study
-
The Freezing of Gait Change of Direction (FOG-COD) Test: A Novel Measure to Predict Falls
-
The functional and lipidome signature of GBA1 mutant dopaminergic neurons
-
The functional consequences of the ‘African GBA1 allele’ of rs3115534 in Parkinson’s Disease
-
The Genetic Landscape of Parkinson’s Disease in an Italian Cohort and the Need for a Standardized Approach
-
The HIIT-Home4Parkinson’s study
-
The Impact of Apathy and Impulsivity on Caregivers in Atypical Parkinsonian Syndromes
-
The Impact of Bilateral STN- Deep Brain Stimulation on Motor Symptoms and Quality Of Life in Advanced Parkinson’s Disease: A Single Center’s Experience
-
The Impact of Camp Lejeune Toxins on the Development of Parkinsonisms and Movement Disorders
-
The impact of cognitive impairment and Alzheimer’s disease neuropathological changes on gait and falls in Parkinson’s disease
-
The impact of Deep Brain Stimulation for Parkinson’s disease on Quality of Life
-
The Impact of Deep Brain Stimulation on the Embarrassment and Self-Esteem of Patients with Essential Tremor
-
The Impact of Drug Interactions on the results of DAT-SPECT Imaging in a Specialty Movement Disorders Practice: A Retrospective Analysis of Outcomes
-
The impact of long-term continuous subcutaneous apomorphine infusion on the reduction of remaining medications in levodopa equivalent dosage and on increasing plasma vitamin B12 levels in patients with advanced Parkinson’s disease
-
The impact of multimodal forms of art therapy on treatment outcomes and quality of life in Parkinson’s disease
-
The Impact of Parkinson’s Disease on Causal Perception
-
The Impact of Standardized Recommendations on the Management of Initial and Refractory Pediatric Status Dystonicus
-
The impact of stimulation setting on Battery Longevity in Deep Brain Stimulation
-
The Impact of VPS35 D620N Mutation on Alternative Autophagy and its Reversal by Estrogen in Parkinson’s Disease
-
The Inhibition of Mitochondrial NLRP3 Inflammasome Decreases Dopaminergic Cell Death in a 6-OHDA Mouse Model of Parkinson’s Disease.
-
The Intention Component of Postural Tremor in Essential Tremor
-
The international validation of the “Stepped Care” toolkit for comprehensive real life clinical care: bridging massive unmet need in care of Parkinson’s disease.
-
The Landscape of Interdisciplinary Care for Atypical Parkinsonism: A Qualitative Study from the CurePSP Centers of Care
-
The Landscape of Neurodegeneration with Brain Iron Accumulation in Indian patients: Lessons from a Multicentric Cross-sectional Study
-
The links between frontal deficits and levels of inflammatory parameters in Progressive Supranuclear Palsy
-
The LRRK2 I1371V mutation alters membrane dynamics and inflammatory profile of astrocytes differentiated from LRRK2-I1371V PD Patient iPSCs
-
The neural contributions to fear of falling avoidance behavior in Parkinson’s disease: preliminary evidence from a mobile neuroimaging paradigm
-
The Neuroprotective Effects of Rolipram, a Selective Phosphodiesterase IV Inhibitor, on Parkinson’s Disease in Rat Models: A Pharmacological Exploration in both In vivo and In vitro Settings
-
The Next Move in Movement Disorders: Differentiating between Hyperkinetic Movement Disorders using [18F] FDG PET
-
The NINDS Approach to Therapeutic Development for Ultra-Rare Neurological Disorders, Bridging Translational and Clinical Frontiers in Gene-based Therapy
-
The novel Gait Cycle Detection Network (GCDN) for Video based gait Analysis based on single 2D RGB video
-
The Potential for Rational Immune System Manipulation to Prevent Emergence of Synucleinopathy Manifestations in Persons with REM Sleep Behavior Disorder (RBD)
-
The potential role of monocytes a-synuclein and lipids as predictors of PD.
-
The Prevalence of Parkinson’s Disease with Dementia in a door to door survey done in a rural district in Hai, Kilimanjaro.
-
The Pro-LBD Study Investigating Early Detection, Prognosis, and Biomarkers of Prodromal Lewy Body Diseases
-
The Profile of Cerebellar Ataxia in Neurology Patients at National Tertiary Referral Hospital in Indonesia
-
The Prospect of Exoskeletons for Individuals with Parkinson’s Disease: A Comprehensive Review
-
The Protective Effect of Sutherlandia frutescens in a Rotenone-Induced Rat Model of Parkinson’s Disease.
-
The Protective Role of Lysosomal Damage Response in Preventing α-Synuclein Propagation
-
The Purely Thermodynamic Anti-prionic Mode of Action for the Treatment of Parkinson’s Disease and other Neurodegenerative Diseases
-
The relationship between dimensions of mental health and markers of Parkinson’s disease risk in the UK Biobank
-
The relationship between pain threshold and striatal dopamine function in Parkinson’s Disease
-
The Role of a Social Worker in a Deep Brain Stimulation Multidisciplinary Team
-
The role of cognitive functions on the outcomes of an intensive multidisciplinary rehabilitation program for people with Parkinson’s disease
-
The Role of Cortisol a Mediator in Influencing Cognitive Function
-
The role of extracellular vesicles in the progression of Parkinson’s disease
-
The role of LRRK2 in regulating microglial activity in Parkinson’s disease
-
the role of metabotropic glutamate receptors type 3 and 5 in parkinson’s disease: analysis of grm3 and grm5 genbe variants.
-
The role of pathology validation on the association between smoking and Parkinson’s Disease
-
the role of the “unfolded protein response” and the perk pathway in parkinson’s disease: study of genetic polymorphisms
-
The Spatiotemporal Characteristics of Floor Sitting Rising in Parkinson’s Disease (PD)
-
The Spectrum of Presenting Phenotypes in Childhood Onset Huntingtons Disease
-
The study of evaluating the impact of simulating indoor environments using virtual reality on gait in Parkinson’s Disease
-
The Use of Biometric Feedback Devices for Stratification of Deep Brain Stimulation (DBS) Eligibility and Treatment Response in Parkinson Disease
-
The use of modelling in Huntington’s disease
-
The value of DaT SPECT in rare movement disorders: acquired diseases
-
The Yips in Golf: Is it a Task-Specific Dystonia ?
-
Therapeutic challenges of long-standing chelator therapy in Wilson’s Disease
-
Therapeutic effects of PNF techniques versus standard physiotherapy exercise on diaphragmatic muscle activity in in the treatment young onsets of Parkinsons survivors
-
Therapeutic restoration of Faecalibacterium prausnitzii in Parkinson’s disease using targeted fructoligosaccharides: a double-blind, placebo-controlled, cross-over trial
-
Three-Year Progression of the Postural Control Alterations in Hereditary Spastic Paraplegias
-
Time To Access Deep Brain Stimulation Surgery for Movement Disorders: A Canadian Single Center Study
-
Time To Rethink the Measurement of Tremor in Early-Stage Parkinson’s Disease
-
Time-Restricted Eating in Huntington’s Disease: Review of the Literature and a Proposed Clinical Trial
-
Tissue-Engineered Nigrostriatal Pathways: An Anatomically-Inspired Model of Synucleinopathy in Human Neurons
-
TM9SF2 Knockdown Decreases Pathological Alpha-synuclein Aggregation In Vivo
-
To develop and study the efficacy of Telephonic Psychotherapy on the Global Neuropsychological functioning of PD Patients: An RCT
-
TOPAS-MSA: Targeting Oligomer Pathology of Alpha-Synuclein – A Study Evaluating the Safety and Efficacy of Emrusolmin in Patients with Multiple System Atrophy
-
Touchscreen performance in people with Parkinson’s Disease
-
Tractography-guided versus Clinical Determination of the Most Effective Contact for Tremor Control in Patients with Deep Brain Stimulation – A Clinical Trial
-
Transcranial Direct Current Stimulation and Neurofunctional Physical Therapy Improves Motor and Cognitive Symptoms in a Patient with Type 1 Spinocerebellar Ataxia – A Case Report
-
Transcranial Direct Current Stimulation for Freezing of Gait in Parkinson’s Disease
-
Transcranial Magnetic Stimulation of Median Prefrontal Cortex Improves Orthostatic Hypotension in Parkinson’s Disease
-
Transcranial magnetic stimulation target comparison identifies motor network reorganization associated with behavioral improvement in writer’s cramp dystonia
-
Transcranial Sonography of the Substantia Nigra and Vagus Nerve Ultrasonography as Complementary Diagnosis for Parkinson’s Disease.
-
Transcriptome analysis of proteasome and inflammation in the substantia nigra of Parkinson’s disease patients: the GEO database.
-
Transcriptomic and Proteomic Profiling for Effective Deep Brain Stimulation in Parkinson’s Disease
-
Transcutaneous tibial nerve stimulation for overactive bladder symptoms in Parkinson’s disease: results from a phase II randomised control trial (STRIPE)
-
Transforming Parkinson’s Care in Africa: Establishing a Global Virtual Support Group for Africans Impacted by Parkinson’s Disease
-
Transforming Parkinson’s Care in Africa: Establishing the First Ever Support Group for People With Parkinson’s Disease and Their Caregivers in Tanzania.
-
Transition from Zinc Salts to Trientine Tetrahydrochloride in Wilson Disease: Clinical and Biochemical Effects over Two Years – the ZICUP study
-
Treatment Effect Sizes of Once-Daily Valbenazine for Tardive Dyskinesia and for Chorea Associated with Huntington’s Disease: A Post-Hoc Analysis of Phase 3 Clinical Trial Data
-
Treatment of Craniofacial Dystonias with Methylphenidate: A Case Series.
-
Treatment of Post-hypoxic Myoclonus using Bilateral Subthalamic Nuclei Deep Brain Stimulation
-
Treatment of Severe Tardive Syndrome with Pallidotomy: A Case Report
-
Treatment of status dystonicus in children using pallidal deep brain stimulation
-
Treatment Patterns and Comorbidities Associated with Multiple System Atrophy: A Comparative Study
-
Treatment Patterns in Essential Tremor: Real-World Evidence from Germany
-
Treatment Patterns With Long-Term Foslevodopa/Foscarbidopa Use in Parkinson’s Disease
-
Tremor and dizziness in a psychiatric patient
-
Tremors Vs. Tremors: the first music album from Parkinson’s tremors
-
Tremulous Machado-Joseph Disease
-
Trend-Analysis of Movement Disorders, Malignant Neoplasms and Mortality from 1999-2020
-
Trends in Physiotherapy Interventions and Medical Costs for Parkinson’s Disease in South Korea, 2011–2020
-
Trihexyphenidyl Use in a Parkinsonian Phenotype of Gerstman-Sträussler-Scheinker Syndrome
-
Triple threat: A rare case of a patient with 3 co-existent autoimmune antibodies causing autonomic and movement disorder
-
TrkB modulator OT-003 reduces dopaminergic cell loss, mitochondrial stress, alpha-synuclein aggregation and motor dysfunction in Parkinson’s disease models.
-
TRPV1: A Potential Therapeutic Target for Inflammation and Pain in Parkinson’s Disease
-
Two Cases of Moyamoya Syndrome-Associated Chorea and Dystonia
-
Two parallel nigrostriatal subcircuits mediate the arousal effect of dopaminergic neurons in substantia nigra pars compacta
-
Two unusual cases of dopamine dysregulation syndrome in patients with Parkinson’s disease
-
Two-year longitudinal evaluation of ataxia and brain structural changes in RFC1-related disorder
2024 International Congress
September 27-October 1, 2024. Philadelphia, PA.